Onderzoeker
Bouke de Jong
Affiliaties
- Mycobacteriologie (Onderzoekseenheid)
Lid
Vanaf1 sep 2010 → Heden - Mycobacteriologie (Onderzoekseenheid)
Lid
Vanaf31 aug 2010 → 16 apr 2015
Projecten
21 - 30 of 75
- EndTB-Q Output 5 testing new regimens to treat MDR-TB resistant to fluoroquinilonesVanaf1 jul 2020 → Heden
- MSF Routine ServicesVanaf1 mrt 2020 → 28 feb 2024
- Alternative techniques for monitoring of rifampicin resistant TB treatment response, to replace systematic monitoring by cultureVanaf1 jan 2020 → 31 dec 2020
- Innovative diagnostic and therapeutic measures to improve MDR-TB diagnosis and management in Conakry, GuineaVanaf1 jan 2020 → Heden
- Heteroresistentie : occulte bedreiging voor succesvolle behandeling van resistente tuberculosisVanaf1 jan 2020 → 31 dec 2023
- Document false rifampicin resistance of Xpert MTB/RIF in BangladeshVanaf1 jan 2020 → 31 dec 2020
- Effectiveness and tolerability of a short regimen for drug resistant tuberculosis treatment in Kandahar Province, Afghanistan, Uncontrolled Clinical StudyVanaf1 sep 2019 → 30 apr 2022
- Technical assistance and support by the SRL ITM to the NRLs of Georgia and Bangladesh and Proficiency testing for Drug-susceptibility testing (Round 25)Vanaf15 mei 2019 → 31 mei 2020
- Het in kaart brengen van de transmissiedynamiek van Mycobacterium leprae in de Comoren met behulp van innovatieve moleculaire techniekenVanaf11 apr 2019 → Heden
- Treatment of Rifampin-resistsant Tuberculosis with an All-Oral Regimen containing new drugs in Zhytomyr UkraineVanaf1 mrt 2019 → 31 jul 2021
Publicaties
1 - 10 van 172
- The use of Kudoh method for culture of Mycobacterium tuberculosis and Mycobacterium africanum in The Gambia(2024)
Auteurs: Tijan Jobarteh, J. Otu, Ensa Gitteh, FS Mendy, TI Faal-Jawara, Boatema Ofori-Anyinam, Binta Sarr, Abi Janet Riley, Abigail Ayorinde, Bouke de Jong, et al.
- Refined understanding of the impact of the Mycobacterium tuberculosis complex diversity on the intrinsic susceptibility to pretomanid(2024)
Auteurs: Rupasinghe Arachchige Praharshinie Rupasinghe, Rabab Reenaers, Jens Vereecken, Leen Rigouts, W Mulders, Stefan Niemann, Matthias Merker, Claudio U. Koeser, Sari Cogneau, Shaheed Vally Omar, et al.
- Evaluating newly approved drugs in combination regimens for multidrug-resistant tuberculosis with fluoroquinolone resistance (endTB-Q): study protocol for a multi-country randomized controlled trial(2023)
Auteurs: Rupasinghe Arachchige Praharshinie Rupasinghe, S. B. Patil, M. Tamirat, K Khazhidinov, Elisa Ardizzoni, M. Atger, A Austin, E. Baudin, M Bekhit, S Bektasov, et al.
- Rifampicin resistance conferring mutations among Mycobacterium tuberculosis strains in Rwanda(2023)
Auteurs: Isabel Cuella Martin, Jean Claude Semuto Ngabonziza, Gabriela Torrea, Conor J. Meehan, W Mulders, Bertin Ushizimpumu, Louise De Weerdt, Jelle Keysers, Willem Bram de Rijk, T Decroo, et al.
Pagina's: 274-281 - Protocol, rationale and design of BE-PEOPLE (Bedaquiline enhanced exposure prophylaxis for LEprosy in the Comoros): a cluster randomized trial on effectiveness of rifampicin and bedaquiline as post-exposure prophylaxis of leprosy contacts(2023)
Auteurs: Assoumani Younoussa, Said Nourdine Samidine, Auke T Bergeman, Alberto Piubello, Nissad Attoumani, Silahi Halifa Grillone, Sofie Braet, Achilleas Tsoumanis, Abdallah Baco, Aboubacar Mzembaba, et al.
Pagina's: 310 - Community-supported self-administered tuberculosis treatment combined with active tuberculosis screening: a pilot experience in Conakry, Guinea(2023)
Auteurs: Souleymane Hassane-Harouna, Tinne Gils, T Decroo, Nimer Ortuno-Gutierrez, Alexandre Delamou, Gba-Foromo Cherif, Lansana Mady Camara, Leen Rigouts, Bouke de Jong
- Hi-plex deep amplicon sequencing for identification, high-resolution genotyping and multidrug resistance prediction of Mycobacterium leprae directly from patient biopsies by using Deeplex Myc-Lep(2023)
Auteurs: Agathe Jouet, Sofie Braet, Cyril Gaudin, G Bisch, Sidra Ezidio Gonçalves Vasconcellos, REEND do Livramento, YYP Palacios, Amanda B. Fontes, N. Lucena-Silva, Patricia S. Rosa, et al.
- Borderline rpoB mutations transmit at the same rate as common rpoB mutations in a tuberculosis cohort in Bangladesh(2023)
Auteurs: Pauline Lempens, Armand Van Deun, Kya J M Aung, Mohammad A Hossain, Mahboobeh Behruznia, T Decroo, Leen Rigouts, Bouke de Jong, Conor J. Meehan
- Mycobacterium tuberculosis retains viability in RNAlater buffer but not in GTC-TCEP and DNA/RNA Shield(2023)
Auteurs: Lena Krausser, Sofie Braet, Z Benaamar, Magalie Van Dyck-Lippens, Bouke de Jong, Leen Rigouts
Pagina's: 115905 - GeneXpert MTB/RIF Ultra performance to detect uncommon rpoB mutations in Mycobacterium tuberculosis(2023)
Auteurs: Leen Rigouts, Jelle Keysers, Rabab Reenaers, K Fissette, Armand Van Deun, Bouke de Jong